The effects of glucagon-like peptide (GLP)-1 receptor agonists on weight and glycaemic control in Prader-Willi syndrome: A systematic review

The effects of glucagon-like peptide (GLP)-1 receptor agonists on weight and glycaemic control in Prader-Willi syndrome: A systematic review

10.1111/cen.14583

Saved in:

Bibliographic Details
Main Authors:	Ng, Nicholas Beng Hui, Low, Yue Wey, Rajgor, Dimple Dayaram, Low, Jia Ming, Lim, Yvonne Yijuan, Loke, Kah Yin, Lee, Yung Seng
Other Authors:	PAEDIATRICS
Format:	Review
Language:	English
Published:	WILEY 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Endocrinology & Metabolism diabetes mellitus exenatide glucagon-like peptide 1 receptor agonists hyperphagia liraglutide obesity Prader-Willi syndrome PLASMA GHRELIN HYPOTHALAMIC OBESITY YOUNG-ADULTS LIRAGLUTIDE HYPERPHAGIA INHIBITOR APPETITE CHILDREN PATIENT EXENATIDE
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/216305
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Description
Summary:	10.1111/cen.14583